Getty Images
The observational study referenced in this news release suggests that people who have bariatric surgery may have a lower rate of death than those who try to lose weight using nonsurgical alternatives.
Although the study is larger than many similar ones, it suffers from some of the same limitations; mainly difficulties matching the two study groups in such a way that the differences in their outcomes can be attributed to something other than chance.
This news release does touch on these limitations but would have served readers better if it had included more on the costs and risks involved in bariatric surgery, as well as some discussion of nonsurgical alternatives.
As bariatric surgery to treat obesity becomes increasingly popular, there’s growing interest in the potential long-term benefits and risks involved. Bariatric surgeries are booming, even in children. This makes long-term studies addressing safety and efficacy increasingly important.
The decision to pursue bariatric surgery is a complicated one. News releases and published articles touching on this emotionally charged topic serve readers best when they provide a balanced perspective on surgical vs. nonsurgical options, benefits vs. risks, and both the long-term and short-term costs involved.
Three types of bariatric surgery (laparoscopic banding, Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy) are the primary interventions evaluated in this study. The costs for these common weight loss procedures are not mentioned in the news release.
Some information — even broad cost ranges of bariatric surgery compared to nonsurgical care — is warranted.
The release states that “The rate of death from any cause over about 4.5 years was lower among obese patients who underwent bariatric surgery compared with patients who managed their obesity with nonsurgical care.”
The release further notes that “The association between bariatric surgery and a lower rate of death from any cause adds to the limited literature describing the beneficial outcomes of these surgical procedures for obese patients.”
But the results state only that the rates of death were “lower” over the 4.5 year follow up period. There is no attempt to put the size of the difference in context.
The release doesn’t discuss any potential harms associated with bariatric surgery — and there are several. While the focus of this study was on rates of death, not on other outcomes, any discussion of this surgery that might sway a reader to try it needs to include a summary of potential complications and risks.
The issue of harms might have been included in the “limitations” section of the release.
The news release does well in describing this retrospective cohort study as observational and that a significant limitation is the imbalance that occurs in trying to match surgical and nonsurgical groups by age, sex, body mass index, and diabetes status.
It would have been helpful to make it clear that patients were not assigned randomly, and many surgical candidates were excluded because they could not be matched. These limitations, along with some confounding socioeconomic factors, would have been helpful to include in the bulleted section, “Study Limitations,” which we were happy to see included.
There is no disease-mongering in this news release.
Funding sources and conflicts of interest are not addressed in the news release. Is is suggested readers consult the original article (link provided) for more information.
The nonsurgical alternatives to treating obesity are not clearly explained in this news release.
The release doesn’t address availability. However, bariatric surgery for obesity is becoming increasingly common and is now available worldwide. The release would have been stronger had it informed readers about the eligibility criteria for the surgery.
The news release notes that there are many studies looking at the short-term outcomes of bariatric surgery, but less that address longer-term effects, as this one does.
There is no unjustifiable language employed.
Systematic, Criteria-Driven
I miss @HealthNewsRevu popping up in my feed. Loved seeing this one today.
https://www.healthnewsreview.org/2021/06/zombie-health-care-news/
#healthcare #journalism #ethics #conflictofinterest
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like